Vitamin C treatment reduces transcapillary escape rate of albumin in type 1 diabetes

2004 ◽  
Vol 15 (7) ◽  
pp. 428-435 ◽  
Author(s):  
Bente Juhl ◽  
Flemming Klein ◽  
Jens Sandahl Christiansen
Diabetologia ◽  
2019 ◽  
Vol 63 (2) ◽  
pp. 278-286 ◽  
Author(s):  
Markus Mattila ◽  
◽  
Iris Erlund ◽  
Hye-Seung Lee ◽  
Sari Niinistö ◽  
...  

Abstract Aims/hypothesis We studied the association of plasma ascorbic acid with the risk of developing islet autoimmunity and type 1 diabetes and examined whether SNPs in vitamin C transport genes modify these associations. Furthermore, we aimed to determine whether the SNPs themselves are associated with the risk of islet autoimmunity or type 1 diabetes. Methods We used a risk set sampled nested case–control design within an ongoing international multicentre observational study: The Environmental Determinants of Diabetes in the Young (TEDDY). The TEDDY study followed children with increased genetic risk from birth to endpoints of islet autoantibodies (350 cases, 974 controls) and type 1 diabetes (102 cases, 282 controls) in six clinical centres. Control participants were matched for family history of type 1 diabetes, clinical centre and sex. Plasma ascorbic acid concentration was measured at ages 6 and 12 months and then annually up to age 6 years. SNPs in vitamin C transport genes were genotyped using the ImmunoChip custom microarray. Comparisons were adjusted for HLA genotypes and for background population stratification. Results Childhood plasma ascorbic acid (mean ± SD 10.76 ± 3.54 mg/l in controls) was inversely associated with islet autoimmunity risk (adjusted OR 0.96 [95% CI 0.92, 0.99] per +1 mg/l), particularly islet autoimmunity, starting with insulin autoantibodies (OR 0.94 [95% CI 0.88, 0.99]), but not with type 1 diabetes risk (OR 0.93 [95% Cl 0.86, 1.02]). The SLC2A2 rs5400 SNP was associated with increased risk of type 1 diabetes (OR 1.77 [95% CI 1.12, 2.80]), independent of plasma ascorbic acid (OR 0.92 [95% CI 0.84, 1.00]). Conclusions/interpretation Higher plasma ascorbic acid levels may protect against islet autoimmunity in children genetically at risk for type 1 diabetes. Further studies are warranted to confirm these findings. Data availability The datasets generated and analysed during the current study will be made available in the NIDDK Central Repository at https://www.niddkrepository.org/studies/teddy.


2016 ◽  
Vol 86 (5-6) ◽  
pp. 184-189 ◽  
Author(s):  
Bente Juhl ◽  
Finn Friis Lauszus ◽  
Jens Lykkesfeldt

Abstract.Few studies have examined how vitamin C status is affected in diabetic pregnancy and no comparison between normal and diabetic pregnancies has been found. This study evaluated vitamin C status prospectively during pregnancy in women with type 1 diabetes mellitus (n=76), in non-diabetic women (n=60), and in their respective neonates. Vitamin C was lower in diabetic women throughout all trimesters compared to controls (p<0.01). Repeated measurements analysis showed significant differences between diabetic and non-diabetic women; also when adjusted for birth weight ratio and age. In non-diabetic women, vitamin C levels were lower in 3rd trimester compared to 1st and 2nd trimester (both p<0.05). Poor vitamin C status - defined as a plasma concentration <23µM - was found in 51% and 12% of the diabetic and nondiabetic women, respectively, at some stage during pregnancy. Umbilical cord vitamin C levels were higher than in the diabetic as well as in the non-diabetic mothers (p<0.01). The umbilical vitamin C was two to three times higher than maternal vitamin C. In conclusion, our results suggests that vitamin C status is lower in pregnant women with type 1 diabetes, while no effect on vitamin C status was observed in the neonates of diabetic women based on umbilical measurements.


2013 ◽  
Vol 12 (1) ◽  
pp. 97 ◽  
Author(s):  
Antonio Ceriello ◽  
Anna Novials ◽  
Emilio Ortega ◽  
Silvia Canivell ◽  
Gemma Pujadas ◽  
...  

Nutrients ◽  
2021 ◽  
Vol 13 (3) ◽  
pp. 928
Author(s):  
Markus Mattila ◽  
Leena Hakola ◽  
Sari Niinistö ◽  
Heli Tapanainen ◽  
Hanna-Mari Takkinen ◽  
...  

Our aim was to study the associations between maternal vitamin C and iron intake during pregnancy and the offspring’s risk of developing islet autoimmunity and type 1 diabetes. The study was a part of the Finnish Type 1 Diabetes Prediction and Prevention (DIPP) prospective birth cohort including children genetically at risk of type 1 diabetes born between 1997–2004. The diets of 4879 mothers in late pregnancy were assessed with a validated food frequency questionnaire. The outcomes were islet autoimmunity and type 1 diabetes. Cox proportional hazards regression analysis adjusted for energy, family history of diabetes, human leukocyte antigen (HLA) genotype and sex was used for statistical analyses. Total intake of vitamin C or iron from food and supplements was not associated with the risk of islet autoimmunity (vitamin C: HR 0.91: 95% CI (0.80, 1.03), iron: 0.98 (0.87, 1.10)) or type 1 diabetes (vitamin C: 1.01 (0.87, 1.17), iron: 0.92 (0.78, 1.08)), neither was the use of vitamin C or iron supplements associated with the outcomes. In conclusion, no association was found between maternal vitamin C or iron intake during pregnancy and the risk of islet autoimmunity or type 1 diabetes in the offspring.


Sign in / Sign up

Export Citation Format

Share Document